Wikipedia:Articles for deletion/Perspective (pharmacoeconomic)

The following discussion is an archived debate of the proposed deletion of the article below. Please do not modify it. Subsequent comments should be made on the appropriate discussion page (such as the article's talk page or in a deletion review). No further edits should be made to this page.

The result was delete‎. If an editor wants to work on this article in Draft space, let me know. Liz ^{Read! Talk!} 08:00, 11 December 2023 (UTC)[reply]

Perspective (pharmacoeconomic)

[Hide this box] New to Articles for deletion (AfD)? Read these primers!

(Find sources: Google (books · news · scholar · free images · WP refs) · FENS · JSTOR · TWL)

A WP:DICDEF. [1] defines the term in table 1 as "the different viewpoints from which health benefits and costs can be assessed (e.g., patient, provider, payer, society in general)". Could be added to wikt:perspective. Darcyisverycute (talk) 07:41, 4 December 2023 (UTC)[reply]

Note: This discussion has been included in the deletion sorting lists for the following topics: Health and fitness and Economics. Darcyisverycute (talk) 07:41, 4 December 2023 (UTC)[reply]
Draftify. I don't think such specific usage in a narrow field would fit in Wiktionary any more than Perspective (graphical) does. A better sourced article here would be nice, but seeing as the page remained largely unchanged since 2007, I wouldn't be too disappointed if it is deleted. Owen× ☎ 23:52, 4 December 2023 (UTC)[reply]
Delete -- The article is currently unsourced entirely, and I cannot find a hint of scholarly sources that mention the concept. To be fair, the signal-to-noise is vile on searches for perspective of any kind, but without at least something in the article, draftifying (or keeping) in hope sources will be found is just wishful thinking, imo. Cheers, Last1in (talk) 23:57, 7 December 2023 (UTC)[reply]
There are quite a few academic papers in pharmacoeconomics that use the term. For example, this one includes the following:
With any sort of cost analysis, perspective (cost to whom) matters. Perspectives for pharmacoeconomics analyses include the patient, provider, payer, and the broader societal perspective (including all costs) with the payer or societal perspective being the most common in the published literature.
And this paper is focused on the term. Owen× ☎ 12:15, 8 December 2023 (UTC)[reply]

The above discussion is preserved as an archive of the debate. Please do not modify it. Subsequent comments should be made on the appropriate discussion page (such as the article's talk page or in a deletion review). No further edits should be made to this page.